Simplex Trading
CAPR icon

Simplex Trading’s Capricor Therapeutics CAPR Stock Holding History

Simplex Trading’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.02M Buy
99,300
+31,400
+46% +$837K ﹤0.01% 1499
2025
Q4 		$1.96M Sell
67,900
-102,500
-60% -$1.34M ﹤0.01% 2001
2025
Q3 		$1.23M Sell
170,400
-176,400
-51% -$1.3M ﹤0.01% 2833
2025
Q2 		$3.44M Buy
346,800
+269,200
+347% +$2.84M ﹤0.01% 1656
2025
Q1 		$736K Sell
77,600
-32,800
-30% -$455K ﹤0.01% 2996
2024
Q4 		$1.52M Buy
110,400
+52,700
+91% +$923K ﹤0.01% 2440
2024
Q3 		$877K Buy
57,700
+54,500
+1,703% +$270K ﹤0.01% 3040
2024
Q2 		$15K Sell
3,200
-2,500
-44% -$13.9K ﹤0.01% 7112
2024
Q1 		$38K Sell
5,700
-5,600
-50% -$27.1K ﹤0.01% 6509
2023
Q4 		$55K Sell
11,300
-2,900
-20% -$9.44K ﹤0.01% 5988
2023
Q3 		$48K Buy
14,200
+5,000
+54% +$28.1K ﹤0.01% 5836
2023
Q2 		$43K Sell
9,200
-7,400
-45% -$32.5K ﹤0.01% 5982
2023
Q1 		$70K Sell
16,600
-28,400
-63% -$122K ﹤0.01% 5538
2022
Q4 		$173K Sell
45,000
-9,900
-18% -$47.3K ﹤0.01% 4393
2022
Q3 		$329K Buy
54,900
+7,000
+15% +$35.8K ﹤0.01% 3967
2022
Q2 		$167K Buy
47,900
+23,900
+100% +$84.8K ﹤0.01% 4845
2022
Q1 		$82K Sell
24,000
-19,800
-45% -$78.1K ﹤0.01% 6428
2021
Q4 		$128K Sell
43,800
-4,200
-9% -$14.7K ﹤0.01% 5854
2021
Q3 		$244K Hold
48,000
– – ﹤0.01% 5274
2021
Q2 		$246K Buy
48,000
+47,512
+9,736% +$201K ﹤0.01% 5336
2021
Q1 		$228K Buy
488
+449
+1,151% +$2.59K ﹤0.01% 4553
2020
Q4 		$13K Buy
39
+10
+34% +$43 ﹤0.01% 7235
2020
Q3 		$15K Sell
29
-16
-36% -$93 ﹤0.01% 6546
2020
Q2 		$20K Buy
+45
New +$196 ﹤0.01% 6208

Other funds holding CAPR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Simplex Trading's CAPR Position: Q1 2026 in Review

Simplex Trading sold out of Capricor Therapeutics (CAPR) in Q1 2026, closing a stake of 55,707 shares — an estimated $1.48M sold.

Simplex Trading first reported a position in CAPR in Q2 2020 and held it in 17 quarters. The position peaked at $1.61M in Q4 2025. 177 funds tracked by Wall St. Rank hold CAPR as of Q1 2026.

  • Simplex Trading reported no remaining Capricor Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 55,707 Capricor Therapeutics shares in Q1 2026, an estimated $1.48M.
  • Simplex Trading first reported a position in Capricor Therapeutics in Q2 2020 and held it in 17 quarters.
  • Simplex Trading's Capricor Therapeutics position peaked at $1.61M in Q4 2025.
  • 177 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.